IP Library › Granted Patent US 10,160,964
Granted Patent B2
US 10,160,964 · App. 15/147,969 · Granted Dec 25, 2018

Methods for extracellular vesicle isolation and selective removal

Inventor: Yousef Haj-Ahmad (St. Catharines, CA)
Assignee: Norgen Biotek Corp.
C12N15/1006C12N15/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,160,964
App. No.
15/147,969
Granted
Dec 25, 2018
Kind
B2
Abstract

Disclosed is a method for the isolation of extracellular vesicles, including exosomes, from a liquid sample, the method comprising the steps of: adjusting the pH of a liquid sample comprising extracellular vesicles to a preselected, binding pH; contacting the liquid sample with silicon carbide, wherein at the preselected, binding pH, the extracellular vesicles bind to the silicon carbide; and eluting the bound extracellular vesicles from the silicon carbide. The liquid samples can comprise bodily fluids. Further disclosed is a method for producing a liquid sample, substantially depleted of extracellular vesicles, including exosomes.

Claims (14)

1. A method for the isolation of extracellular vesicles from a liquid sample, the method comprising the steps of:

(a) adjusting the pH of a liquid sample comprising extracellular vesicles to a preselected, binding pH;

(b) contacting the liquid sample with silicon carbide, wherein at the preselected, binding pH, the extracellular vesicles bind to the silicon carbide; and

(c) eluting the bound extracellular vesicles from the silicon carbide;

wherein steps (a) and (b) can be carried out in any order or simultaneously.

2. The method of claim 1 , wherein the isolated extracellular vesicles comprise exosomes.

3. The method of claim 1 , wherein the liquid sample comprises cell culture media or a biological fluid, wherein the biological fluid is whole blood, blood serum, plasma, urine, saliva, sputum, breast milk, ascetic fluid, semen, vaginal fluid, amniotic fluid, cerebrospinal fluid, sweat or tears.

4. The method of claim 1 , wherein the silicon carbide is in a slurry format or the silicon carbide is packed into a solid support column.

5. The method of claim 4 , wherein the silicon carbide is in a slurry format, and wherein step (b) occurs before step (a), such that the liquid sample is contacted with the silicon carbide before the pH of the liquid sample is adjusted to the preselected binding pH to affect binding of the extracellular vesicles to the silicon carbide.

6. The method of claim 4 , wherein the silicon carbide is in a slurry format, and wherein prior to eluting the bound extracellular vesicles from the silicon carbide, the method further comprises the step of separating the silicon carbide with the bound extracellular vesicles from the liquid sample by centrifugation or by gravity settling.

7. The method of claim 1 , wherein preselected, binding pH is about 7 to about 11.

8. The method of claim 7 , wherein the preselected, binding pH is about 8.5.

9. The method of claim 1 , wherein the bound extracellular vesicles are eluted from the silicon carbide using a low salt buffer having a pH of about 4 to about 6.

10. The method of claim 1 , wherein the isolated extracellular vesicles have an average diameter of about 40 nm to about 150 nm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2016
From: HAJ-AHMAD, YOUSEF
To: NORGEN BIOTEK CORP.
Reel/Frame 038483/0578 →
Continuity (2)
Provisional Application 62160647 · May 13, 2015
Related Publication 20160333338A1 · Nov 17, 2016
Cited By (1)
US 1,101,143